The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories View More Recent Stories
-
Dealmakers, investors descend on Singapore for high-profile conferences
-
Dealmakers, investors descend on Singapore for high-profile conferences
-
Marcus & Millichap and Project Destined Announce Expanded Partnership
-
The Carlyle Group (CG) to Sell Sequa to Veritas
-
Mainardo de Nardis and Laura Held Join VidMob Board of Directors
-
Catalyst Pharmaceuticals (CPRX) to Join S&P SmallCap 600
-
Catalyst Pharmaceuticals Set to Join S&P SmallCap 600
-
Catalyst Pharmaceuticals (CPRX) to Join SmallCap 600
-
Yes Bank to approve J.C. Flowers as buyer for its $6 billion stressed loan portfolio
-
Francisco Partners Hires Ashley Evans as Partner
-
Greenberg Traurig's Kemal Hawa to Moderate TMT M&A Forum 2022 Panel
-
Nissan Approves Fermata Energy’s Bidirectional Charger as First for Use with Nissan LEAF in the U.S.
-
VTEX and Adyen partner to bring unified commerce to enterprise brands and retailers
-
Kim Kardashian to launch private equity firm with former Carlyle partner
-
Kim Kardashian Taps Former Carlyle Partner to Run Her Private Equity Firm - DJ
-
The Carlyle Group (CG) Management Change Could Adversely Impact Business - BofA
-
UPDATE: BofA Securities Double Downgrades The Carlyle Group LP (CG) to Underperform
-
disguise's Polygon Labs acquisition delivers the ultimate solution for broadcast graphics production
-
GeoVax Announces Addition to Its Board of Directors
-
GeoVax Announces Addition to Its Board of Directors
-
Greystone and Project Destined Deepen Career Development Impact with Two New Programs
-
Hilb Group Acquires Massachusetts-based Cook & Company Insurance Services, Adds to New England Presence
-
Epic Decade announces the formation of Curiosity & Co., launching a new era of century-scale systems design
-
Carlyle Group Shows New 12.8% Stake in MKS Instruments (MKSI) Following Atotech Merger
-
Form SC 13G MKS INSTRUMENTS INC Filed by: Carlyle Group Inc.
-
Two Six Technologies Announces Public Release of Coffeebreak
-
Japan's Olympus to sell microscope unit to Bain for $3 billion
-
Net Health Announces Two New Executive Appointments as Company Expands Focus On Analytics and Intelligent EHRs
-
Involta Expands Its Cleveland Market Data Center
-
Tessera Therapeutics Expands Leadership and Board
-
Olympus nearing deal to sell microscope unit for over $2 billion - sources
-
Hilb Group Names Darren Cohen Carrier Relations and Insurance Strategy Leader; Builds on Focus to Strengthen Offerings for Clients and Agency Partners
-
S.Korean EV battery maker SK On raises $1.5 billion in expansion push -report
-
U.S. on track to break record for the most products recalled in a single year
-
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
-
Involta Appoints Data Center Industry Leader to Its Board of Directors
-
Abrigo expands lending automation with acquisition of BankLabs' Construct and +Pay technologies
-
Form 13F-HR Carlyle Group Inc. For: Jun 30
-
Analysis: How Carlyle CEO Kewsong Lee's turnaround of the private equity firm was cut short
-
Form SC 13D/A EXICURE, INC. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Vera Therapeutics, Inc. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Adicet Bio, Inc. Filed by: Carlyle Group Inc.
-
Form SC 13D/A NuCana plc Filed by: Carlyle Group Inc.
-
Form SC 13D/A eFFECTOR Therapeutics, Filed by: Carlyle Group Inc.
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
Form SC 13D/A Reneo Pharmaceuticals, Filed by: Carlyle Group Inc.
-
Form SC 13D/A SPRUCE BIOSCIENCES, INC. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Jasper Therapeutics, Filed by: Carlyle Group Inc.
-
Sciens Building Solutions Finalizes San Antonio Acquisition
-
Form 4 ZoomInfo Technologies For: Aug 05 Filed by: Carlyle Group Inc.

